Chemical Component Summary | |
---|---|
Name | Masitinib |
Identifiers | 4-[(4-methylpiperazin-1-yl)methyl]-~{N}-[4-methyl-3-[(4-pyridin-3-yl-1,3-thiazol-2-yl)amino]phenyl]benzamide |
Formula | C28 H30 N6 O S |
Molecular Weight | 498.642 |
Type | NON-POLYMER |
Isomeric SMILES | Cc1ccc(cc1Nc2nc(cs2)c3cccnc3)NC(=O)c4ccc(cc4)CN5CCN(CC5)C |
InChI | InChI=1S/C28H30N6OS/c1-20-5-10-24(16-25(20)31-28-32-26(19-36-28)23-4-3-11-29-17-23)30-27(35)22-8-6-21(7-9-22)18-34-14-12-33(2)13-15-34/h3-11,16-17,19H,12-15,18H2,1-2H3,(H,30,35)(H,31,32) |
InChIKey | WJEOLQLKVOPQFV-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 66 |
Chiral Atom Count | 0 |
Bond Count | 70 |
Aromatic Bond Count | 23 |
Drug Info: DrugBank
DrugBank ID | DB11526 |
---|---|
Name | Masitinib |
Groups |
|
Description | Masitinib is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in dogs. It has been available in Europe since 2009, under the brand name Masivet. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011. |
Synonyms |
|
Categories |
|
ATC-Code | L01EX06 |
CAS number | 790299-79-5 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1908391 |
PubChem | 10074640 |
ChEMBL | CHEMBL1908391 |
ChEBI | CHEBI:63450 |